S. Korea's Celltrion says top shareholder drops plan to sell stake
SEOUL, July 2
SEOUL, July 2 (Reuters) - Celltrion Inc said on Wednesday its top shareholder is no longer considering a sale of a stake in the biotechnology company.
Founder and Chief Executive Seo Jung-jin last year said he would seek a buyer among multinational drugmakers for his controlling interest in the company.
Celltrion is the largest stock on South Korea's junior bourse with a market value of 4.87 trillion won ($4.83 billion) as of Wednesday's close.
($1 = 1009.1000 South Korean Won) (Reporting by Joyce Lee; Editing by Christopher Cushing)
- IPhone emerges from 'bygone era', reviewers hail bigger handset
- On eve of secession vote, UK's fate hangs on a divided Scotland |
- Fed renews zero rate pledge, but hints at steeper rate hike path
- Boeing, SpaceX win contracts to build 'space taxis' for NASA
- Islamic State campaign tests Obama's commitment to Mideast allies